These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20814659)

  • 1. Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma.
    Platteaux N; Dirix P; Hermans R; Nuyts S
    Strahlenther Onkol; 2010 Sep; 186(9):517-20. PubMed ID: 20814659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.
    Chen AM; Wang PC; Daly ME; Cui J; Hall WH; Vijayakumar S; Phillips TL; Farwell DG; Purdy JA
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):771-7. PubMed ID: 24606846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.
    Thomas TO; Refaat T; Choi M; Bacchus I; Sachdev S; Rademaker AW; Sathiaseelan V; Karagianis A; Mittal BB
    Radiat Oncol; 2015 Apr; 10():94. PubMed ID: 25927572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.
    Amini A; Yang J; Williamson R; McBurney ML; Erasmus J; Allen PK; Karhade M; Komaki R; Liao Z; Gomez D; Cox J; Dong L; Welsh J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e391-8. PubMed ID: 22284035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer.
    Metcalfe E; Etiz D
    Contemp Oncol (Pozn); 2016; 20(1):67-72. PubMed ID: 27095943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.
    Mutter RW; Lok BH; Dutta PR; Riaz N; Setton J; Berry SL; Goenka A; Zhang Z; Rao SS; Wolden SL; Lee NY
    Radiat Oncol; 2013 Jul; 8():173. PubMed ID: 23835205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Prakash BB; Yathiraj PH; Sharan TK; Singh A; Reddy AS; Chandraguthi SG; Subramanian RB; Nagesh J; Nair SS; Fernandes DJ; Mamidipudi VS
    J Cancer Res Ther; 2019; 15(3):522-527. PubMed ID: 31169214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.
    Eblan MJ; Corradetti MN; Lukens JN; Xanthopoulos E; Mitra N; Christodouleas JP; Grover S; Fernandes AT; Langer CJ; Evans TL; Stevenson J; Rengan R; Apisarnthanarax S
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):175-81. PubMed ID: 22658442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
    Yi SK; Hall WH; Mathai M; Dublin AB; Gupta V; Purdy JA; Chen AM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1060-4. PubMed ID: 21536393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.
    Chen AM; Hall WH; Li J; Beckett L; Farwell DG; Lau DH; Purdy JA
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):165-9. PubMed ID: 22444998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume modeling of brachial plexus-associated neuropathy after radiation therapy for head and neck cancer: in regard to Chen et al.
    Beitler JJ; Jegadeesh NK; Higgins K
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):474-5. PubMed ID: 25304808
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
    Peñagarícano JA; Moros EG; Ratanatharathorn V; Yan Y; Corry P
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1369-75. PubMed ID: 19625138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
    Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ
    Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
    Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.